Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

What Made Her Give Up Her Breasts: a Qualitative Study on Decisional Considerations for Contralateral Prophylactic Mastectomy among Breast Cancer Survivors Undergoing BRCA1/2 Genetic Testing

  • Kwong, Ava (Division of Breast Surgery, The University of Hong Kong) ;
  • Chu, Annie T.W. (Division of Breast Surgery, The University of Hong Kong)
  • Published : 2012.05.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: This qualitative study retrospectively examined the experience and psychological impact of contralateral prophylactic mastectomy (CPM) among Southern Chinese females with unilateral breast cancer history who underwent BRCA1/2 genetic testing. Limited knowledge is available on this topic especially among Asians; therefore, the aim of this study was to acquire insight from Chinese females' subjective perspectives. Methods: A total of 12 semi-structured in-depth interviews, with 11 female BRCA1/BRCA 2 mutated gene carriers and 1 non-carrier with a history of one-sided breast cancer and genetic testing performed by the Hong Kong Hereditary Breast Cancer Family Registry, who subsequently underwent CPM, were assessed using thematic analysis and a Stage Conceptual Model. Breast cancer history, procedures conducted, cosmetic satisfaction, pain, body image and sexuality issues, and cancer risk perception were discussed. Retrieval of medical records using a prospective database was also performed. Results: All participants opted for prophylaxis due to their reservations concerning the efficacy of surveillance and worries of recurrent breast cancer risk. Most participants were satisfied with the overall results and their decision. One-fourth expressed different extents of regrets. Psychological relief and decreased breast cancer risk were stated as major benefits. Spouses' reactions and support were crucial for post-surgery sexual satisfaction and long-term adjustment. Conclusions: Our findings indicate that thorough education on cancer risk and realistic expectations of surgery outcomes are crucial for positive adjustment after CPM. Appropriate genetic counseling and pre-and post-surgery psychological counseling were necessary. This study adds valuable contextual insights into the experiences of living with breast cancer fear and the importance of involving spouses when counseling these patients.

Keywords

References

  1. Antoniou A, Pharoah P D, Narod S, et al (2003). Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet, 72, 1117-30. https://doi.org/10.1086/375033
  2. Bebbington Hatcher M, Fallowfield L J, (2003). A qualitative study looking at the psychosocial implications of bilateral prophylactic mastectomy. Breast, 12, 1-9. https://doi.org/10.1016/S0960-9776(02)00135-2
  3. Bjorkman B, Arner S, Hyden L C, (2008). Phantom breast and other syndromes after mastectomy: eight breast cancer patients describe their experiences over time: a 2-year follow-up study. J Pain, 9, 1018-25. https://doi.org/10.1016/j.jpain.2008.06.003
  4. Brandberg Y, Sandelin K, Erikson S, et al (2008). Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study. J Clin Oncol, 26, 3943-9. https://doi.org/10.1200/JCO.2007.13.9568
  5. Bresser P J, Seynaeve C, Van Gool, et al (2006). Satisfaction with prophylactic mastectomy and breast reconstruction in genetically predisposed women. Plast Reconstr Surg, 117, 1675-82. https://doi.org/10.1097/01.prs.0000217383.99038.f5
  6. Domchek S M, Friebel T M, Neuhausen S L, et al (2006). Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Lancet Oncol, 7, 223-9. https://doi.org/10.1016/S1470-2045(06)70585-X
  7. DudokdeWit A C, Tibben A, Frets P G, et al (1997). BRCA1 in the family: a case description of the psychological implications. Am J Med Genet, 71, 63-71. https://doi.org/10.1002/(SICI)1096-8628(19970711)71:1<63::AID-AJMG12>3.0.CO;2-T
  8. Gill P S, Hunt J P, Guerra A B, et al (2004). A 10-year retrospective review of 758 DIEP flaps for breast reconstruction. Plast Reconstr Surg, 113, 1153-60. https://doi.org/10.1097/01.PRS.0000110328.47206.50
  9. Glaser B G, Strauss A L (1967). The discovery of grounded theory; strategies for qualitative research. Chicago,: Aldine Pub. Co.
  10. Hartmann L C, Schaid D J, Woods J E, et al (1999). Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med, 340, 77-84. https://doi.org/10.1056/NEJM199901143400201
  11. King M C, Marks J H, Mandell J B, Group N Y B C S (2003). Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science, 302, 643-6. https://doi.org/10.1126/science.1088759
  12. Kwong A, Wong C H, Shea C, Suen D T, Choi C L, (2010). Choice of management of southern Chinese BRCA mutation carriers. World J Surg, 34, 1416-26. https://doi.org/10.1007/s00268-010-0477-5
  13. Lerman C, Croyle R (1994). Psychological issues in genetic testing for breast cancer susceptibility. Arch Intern Med, 154, 609-16. https://doi.org/10.1001/archinte.1994.00420060027003
  14. Lloyd S M, Watson M, Oaker G, et al (2000). Understandingthe experience of prophylactic bilateral mastectomy: a qualitative study of ten women. Psychooncology, 9, 473-85. https://doi.org/10.1002/1099-1611(200011/12)9:6<473::AID-PON490>3.0.CO;2-T
  15. Lodder L N, Frets P G, Trijsburg R W, et al (2002). One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery). Breast Cancer Res Treat, 73, 97-112. https://doi.org/10.1023/A:1015269620265
  16. Marchettini P, Formaglio F, Lacerenza M (2001). Iatrogenic painful neuropathic complications of surgery in cancer. Acta Anaesthesiol Scand, 45, 1090-4. https://doi.org/10.1034/j.1399-6576.2001.450907.x
  17. Matlof E T, Shappell H, Brierley K, et al (2000). What would you do? Specialists' perspectives on cancer genetic testing, prophylactic surgery, and insurance discrimination. J Clin Oncol, 18, 2484-92. https://doi.org/10.1200/JCO.2000.18.12.2484
  18. McGaughey A (2006). Body image after bilateral prophylactic mastectomy: an integrative literature review. J Midwifery Womens Health, 51, 45-9. https://doi.org/10.1016/j.jmwh.2005.07.002
  19. Metcalfe K, Gershman S, Lynch H T, et al (2011). Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Br J Cancer, 104, 1384-92. https://doi.org/10.1038/bjc.2011.120
  20. Payne D K, Biggs C, Tran K N, Borgen P I, Massie M J (2000). Women's regrets after bilateral prophylactic mastectomy. Ann Surg Oncol, 7, 150-4. https://doi.org/10.1007/s10434-000-0150-6
  21. Reuben S S, Makari-Judson G, Lurie S D (2004). Evaluation of efficacy of the perioperative administration of venlafaxine XR in the prevention of postmastectomy pain syndrome. J Pain Symptom Manage, 27, 133-9. https://doi.org/10.1016/j.jpainsymman.2003.06.004
  22. Rothemund Y, Grüsser S M, Liebeskind U, Schlag P M, Flor H (2004). Phantom phenomena in mastectomized patients and their relation to chronic and acute pre-mastectomy pain. Pain, 107, 140-6. https://doi.org/10.1016/j.pain.2003.10.007

Cited by

  1. Contralateral prophylactic mastectomy in women with breast cancer: trends, predictors, and areas for future research vol.140, pp.3, 2013, https://doi.org/10.1007/s10549-013-2643-6
  2. genetic testing process vol.11, pp.1, 2014, https://doi.org/10.2217/pme.13.94
  3. Quality of Life and Psychological State in Chinese Breast Cancer Patients Who Received BRCA1/2 Genetic Testing vol.11, pp.7, 2016, https://doi.org/10.1371/journal.pone.0158531
  4. Differences in quality of life between American and Chinese breast cancer survivors vol.24, pp.9, 2016, https://doi.org/10.1007/s00520-016-3195-1
  5. Decision making for breast cancer prevention among women at elevated risk vol.19, pp.1, 2017, https://doi.org/10.1186/s13058-017-0826-5
  6. Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) Mastectomy vol.24, pp.2, 2017, https://doi.org/10.1245/s10434-016-5688-z
  7. The psychosocial impact of contralateral risk reducing mastectomy (CRRM) on women: A rapid review pp.10579249, 2017, https://doi.org/10.1002/pon.4448
  8. Knowledge Regarding and Patterns of Genetic Testing in Patients Newly Diagnosed With Breast Cancer Participating in the iCanDecide Trial pp.0008543X, 2018, https://doi.org/10.1002/cncr.31731
  9. Constructions of Decision Making for Risk-Reducing Mastectomy vol.28, pp.10, 2018, https://doi.org/10.1177/1049732318785372